M&A - FWHC HOLDINGS, LLC
Form Type: SCHEDULE 13D/A
Filing Date: 2025-02-06
Corporate Action: Acquisition
Type: Update
Accession Number: 000119380525000123
Filing Summary: Amendment No. 7 to Statement on Schedule 13D reflects the sale on December 13, 2024, of all shares of Common Stock and securities exchangeable or exercisable for, or convertible into, shares of Common Stock of Innoveren Scientific, Inc. (f/k/a H-Cyte, Inc.) by the Reporting Persons, which include FWHC Holdings, LLC, HOA Capital, LLC, and J. Rex Farrior, III, among others. Post-sale, the Reporting Persons do not beneficially own any Common Stock, representing 0.00% of the outstanding shares. The amendment includes details on the previously beneficially owned securities sold, including shares of Common Stock, Series A Preferred Stock, and warrants. Notably, the amendment states that due to the complexities and volume of the Sale, per share sale pricing cannot be easily determined.
Additional details:
Reporting Person: FWHC Holdings, LLC
Sole Voting Power: 0
Sole Power Of Disposition: 0
Shared Voting Power: 0
Shared Power Of Disposition: 0
Reporting Person: HOA Capital LLC
Sole Voting Power: 0
Sole Power Of Disposition: 0
Shared Voting Power: 0
Shared Power Of Disposition: 0
Reporting Person: J. Rex Farrior
Sole Voting Power: 0
Sole Power Of Disposition: 0
Shared Voting Power: 0
Shared Power Of Disposition: 0
Reporting Person: FWHC Bridge, LLC
Sole Voting Power: 0
Sole Power Of Disposition: 0
Shared Voting Power: 0
Shared Power Of Disposition: 0
Reporting Person: Todd R. Wagner
Sole Voting Power: 0
Sole Power Of Disposition: 0
Shared Voting Power: 0
Shared Power Of Disposition: 0
Reporting Person: FWHC Bridge Friends, LLC
Sole Voting Power: 0
Sole Power Of Disposition: 0
Shared Voting Power: 0
Shared Power Of Disposition: 0
Common Stock Sold: 15,519
Series A Preferred Stock Sold: 33,678,551
Warrants Sold: 224,262
Exercise Price: $14.00
Comments
No comments yet. Be the first to comment!